BFC Planning’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
BFC Planning's REGN Position: Q3 2026 in Review
BFC Planning reduced its Regeneron Pharmaceuticals (REGN) stake by 17% in Q3 2026, selling an estimated $46.1K and leaving 288 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #897.
BFC Planning first reported a position in REGN in Q3 2024 and has held it in 9 quarters since. The position peaked at $365K in Q3 2024. 1,229 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- BFC Planning held 288 shares of Regeneron Pharmaceuticals worth $218K as of Q3 2026.
- BFC Planning sold 61 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $46.1K.
- Regeneron Pharmaceuticals made up 0.01% of BFC Planning's portfolio in Q3 2026, its #897 holding.
- BFC Planning first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Regeneron Pharmaceuticals position peaked at $365K in Q3 2024.
- 1,229 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.